KYORIN Holdings, Inc. (4569.T)

JPY 1448.0

(0.49%)

Net Income Summary of KYORIN Holdings, Inc.

  • KYORIN Holdings, Inc.'s latest annual net income in 2023 was 5.32 Billion JPY , up 12.68% from previous year.
  • KYORIN Holdings, Inc.'s latest quarterly net income in 2024 Q1 was 885 Million JPY , down -37.14% from previous quarter.
  • KYORIN Holdings, Inc. reported an annual net income of 4.72 Billion JPY in 2022, up 20.12% from previous year.
  • KYORIN Holdings, Inc. reported an annual net income of 3.93 Billion JPY in 2021, down -35.86% from previous year.
  • KYORIN Holdings, Inc. reported a quarterly net income of 676 Million JPY for 2023 Q1, up 95.38% from previous quarter.
  • KYORIN Holdings, Inc. reported a quarterly net income of 1.4 Billion JPY for 2023 Q4, down -34.72% from previous quarter.

Annual Net Income Chart of KYORIN Holdings, Inc. (2023 - 2004)

Historical Annual Net Income of KYORIN Holdings, Inc. (2023 - 2004)

Year Net Income Net Income Growth
2023 5.32 Billion JPY 12.68%
2022 4.72 Billion JPY 20.12%
2021 3.93 Billion JPY -35.86%
2020 6.13 Billion JPY -0.31%
2019 6.14 Billion JPY -10.48%
2018 6.86 Billion JPY 4.49%
2017 6.57 Billion JPY -10.01%
2016 7.3 Billion JPY -46.44%
2015 13.63 Billion JPY 13.06%
2014 12.06 Billion JPY 0.32%
2013 12.02 Billion JPY -3.2%
2012 12.42 Billion JPY 34.57%
2011 9.23 Billion JPY -15.52%
2010 10.92 Billion JPY 23.5%
2009 8.84 Billion JPY 334.36%
2008 2.03 Billion JPY -6.94%
2007 2.18 Billion JPY -54.79%
2006 4.84 Billion JPY -7.38%
2005 5.22 Billion JPY 159.71%
2004 2.01 Billion JPY 0.0%

Peer Net Income Comparison of KYORIN Holdings, Inc.

Name Net Income Net Income Difference
Pharma Foods International Co., Ltd. 3.2 Billion JPY -66.053%
Takeda Pharmaceutical Company Limited 144.06 Billion JPY 96.306%
Sumitomo Pharma Co., Ltd. -314.96 Billion JPY 101.69%
Shionogi & Co., Ltd. 162.03 Billion JPY 96.715%
Wakamoto Pharmaceutical Co.,Ltd. 108.95 Million JPY -4784.406%
Nippon Shinyaku Co., Ltd. 25.85 Billion JPY 79.413%
Kaken Pharmaceutical Co., Ltd. 8.02 Billion JPY 33.682%
Eisai Co., Ltd. 42.4 Billion JPY 87.45%
Morishita Jintan Co., Ltd. 697 Million JPY -663.558%
Hisamitsu Pharmaceutical Co., Inc. 13.96 Billion JPY 61.901%
Mochida Pharmaceutical Co., Ltd. 4.54 Billion JPY -17.044%
Fuso Pharmaceutical Industries,Ltd. 1.37 Billion JPY -286.492%
Nippon Chemiphar Co., Ltd. -180 Million JPY 3056.667%
Tsumura & Co. 16.7 Billion JPY 68.145%
Kissei Pharmaceutical Co., Ltd. 11.16 Billion JPY 52.312%
Torii Pharmaceutical Co., Ltd. 4.11 Billion JPY -29.206%
Towa Pharmaceutical Co., Ltd. 16.17 Billion JPY 67.093%
Fuji Pharma Co., Ltd. 3.43 Billion JPY -54.934%
Zeria Pharmaceutical Co., Ltd. 7.73 Billion JPY 31.163%
Taiko Pharmaceutical Co.,Ltd. -4.89 Billion JPY 208.745%
Daito Pharmaceutical Co.,Ltd. 3.29 Billion JPY -61.517%
SymBio Pharmaceuticals Limited -1.96 Billion JPY 371.141%
MedRx Co., Ltd -932 Million JPY 671.03%
Mizuho Medy Co.,Ltd. 3.77 Billion JPY -41.009%
Solasia Pharma K.K. -1.11 Billion JPY 578.597%
Modalis Therapeutics Corporation -2.39 Billion JPY 322.508%
ASKA Pharmaceutical Holdings Co.,Ltd. 7.54 Billion JPY 29.463%
Sawai Group Holdings Co., Ltd. 13.69 Billion JPY 61.139%
Cyfuse Biomedical K.K. -589.21 Million JPY 1003.242%
Toho Holdings Co., Ltd. 20.65 Billion JPY 74.236%
Koa Shoji Holdings Co.,Ltd. 2.94 Billion JPY -80.631%